TrialSignal
Clinical trial intelligence report
The Measurement of VItal SIgns by Lifelight® Data Collect Software in comparisON to the Standard of Care in Acutely Unwell Patients - The VISION-Acute Study
Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.
Generated
Jun 13, 2026
NCT ID
NCT04589923
Status
COMPLETED
Phase
registry-stage
Sponsor
Xim Limited
Executive brief
Investment-Ready Snapshot
The Measurement of VItal SIgns by Lifelight® Data Collect Software in comparisON to the Standard of Care in Acutely Unwell Patients - The VISION-Acute Study is a registry-stage clinical asset sponsored by Xim Limited in Hypertension, Hypoxia, Hypotension. SEO and diligence focus: Lifelight® Data Collect Blood Pressure Group, Lifelight® Data Collect Oxygen Saturation Group, endpoint relevance, enrollment feasibility, competitive positioning, readout timing and IP durability.
Source & freshness
Provenance
https://clinicaltrials.gov/study/NCT04589923
Indication
Hypertension
Modality
medical device
Target
Lifelight® Data Collect Blood Pressure Group, Lifelight® Data Collect Oxygen Saturation Group
Intervention
Lifelight® Data Collect Blood Pressure Group, Lifelight® Data Collect Oxygen Saturation Group
Source record
Protocol Description
Detailed source ingestion pending.
Source record
Outcome Measures
Detailed source ingestion pending.
Source record
Eligibility
Detailed source ingestion pending.
AI analysis
Known Results And Readout Context
Detailed source ingestion pending.
IP intelligence
Patent And IP Landscape
Detailed source ingestion pending.
Source record
Contacts
Detailed source ingestion pending.